Gsa Capital Partners LLP Frequency Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.88 - $3.85 $33,862 - $69,346	18,012 Added 7.3%	264,728 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$1.46 - $2.55 $54,710 - $95,556	37,473 Added 17.91%	246,716 $442,000
Q2 2022 Aug 09, 2022	SELL	$1.03 - $2.03 $95,035 - $187,302	-92,267 Reduced 30.6%	209,243 $314,000
Q1 2022 May 11, 2022	BUY	$1.7 - $5.72 $138,682 - $466,626	81,578 Added 37.09%	301,510 $639,000
Q4 2021 Feb 14, 2022	BUY	$4.95 - $7.11 $684,486 - $983,170	138,280 Added 169.35%	219,932 $1.13 Million
Q3 2021 Nov 12, 2021	BUY	$6.96 - $9.25 $568,297 - $755,281	81,652 New	81,652 $576,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.